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Table. Summary of endoleak channel ﬂow, radiographic detection of the endoleak, sac pressurization as mean arterial
pressure (MAP) and pulse pressure (PP)
Systemic MAP/
aneurysm MAP
(mm Hg)
Systemic PP/
aneurysm
PP (mm Hg)
Net endoleak
ﬂow (cc/min)
Standard angiography/
delayed imaging
(positive/negative
after 30 mins)
No endoleak 113/101 80/10 not applicable negative/negative
Type 1a endoleak
no outﬂow
116/120 84/17 1.27 negative/positive
Type 1a endoleak
with outﬂow
119/105.5 86/12 39 positive/positive
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Aortic Occlusion Hemodynamic Attenuation With
Valproic Acid
Marlin W. Causey, Seth Miller, Niten Singh, Matthew
Martin. Madigan Army Medical Center, Ft. Lewis, Wash
Objectives: Valproic acid (VPA; a histone deacetylase
inhibitor) has demonstrated signiﬁcant decreases in resusci-
tation requirements as well as minimizing pathologic phys-
iology following short term aortic occlusion. The purpose
of this study was to compare the cardiac and hemodynamic
changes with VPA administration following supraceliac
aortic occlusion.
Methods: 19 swine were exposed to a 35% blood
volume hemorrhage followed by a supraceliac aortic cross
clamp only model with valproic acid (400 mg/kg) admin-
istered as a drip continuously during supraceliac aortic cross
clamping (CC, n ¼ 9). Hemodynamics were measured
with the use of arterial blood pressure monitor and
a pulmonary artery thermodilution catheter.
Results: 10 swine were divided into two equal groups-
sham and model. In this validation, hemodynamics were
signiﬁcantly different as measured after hemorrhage and
cross clamp by mean arterial pressure (MAP; P ¼ .024),
heart rate (P < .001), cardiac index (CI; P ¼ .005). In
the comparison arm of control and cross clamp group,
there was a signiﬁcant attenuation in the adverse hemodya-
mic response with administration of VPA (n ¼ 9) during
cross clamp (MAP ¼ 87 6 28 vs CC-122 6 43 mm Hg;
P ¼ .02; HR ¼ 124 6 23 vs CC-161 6 32 bpm; P ¼
.01). Additionally, throughout the cross clamp application,
there was a signiﬁcantly decreased hyperdynamic response
with the administration of VPA (Fig).
Conclusions: VPA helps attenuate the adverse hyper-
dynamic cardiac response following a hemorrhagic event
and subsequent aortic occlusion. The hemodynamic
response appeared to be not only signiﬁcant at each time
interval, but sustained as cross clamp times increased. Addi-
tionally, VPA seemed to minimize pathologic hemody-
namic variation and provide cardiac protection through
minimizing cardiac stress and work of the heart during
aortic occlusion.Author Disclosures: M. W. Causey: Nothing to disclose;
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Preservation of Antegrade Internal Iliac Artery Flow
Using Heilical Branch Devices in Challenging
Anatomic Situations: Technical Succss, Survival and
Patency
Shen Wong, Roy K. Greenberg, Matthew J. Eagleton, Tara
Mastracci, Yuki Kuramochi. Vascular Surgery, Cleveland
Clinic Foundation, Cleveland, Ohio
Objectives: Technical success and patency of iliac
branch devices (IBD) for aortoiliac aneurysms are scarce
Table.
All II aneurysm (35%) IIA stenosis (20%) CIA < 16 mm (46%)
Technical success, % (n ¼ 138) 93 Yes 93 No 93 ns Yes 82 No 96 P ¼ .015 Yes 95 No 92 ns
Endoleak, % 3 7 1 ns 0 4 ns 0 5 ns
Patency, %, 30d 1yr 5yr 95 86 82 98 87 78 93 86 83 ns 89 81 81 96 88 82 ns 92 84 84 97 89 80 ns
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sion of patients with internal iliac artery (IIA) stenosis,
narrow common iliac artery (CIA) diameters and IIA aneu-
rysm has precluded hypogastric preservation in most cases.
Methods: Data was prospectively collected on patients
with infrarenal or thoracoabdominal aortoiliac aneurysms
treated with helical-IBDs (H-IBD). Preoperative aneu-
rysmal characteristics, technical success, patency, reinter-
ventions and endoleaks were noted in accordance with
endovascular reporting standards. Survival and patency
were evaluated with life-table analyses and differences
among anatomic groups compared with log-rank tests.
T-tests and Fisher’s exact tests were used to compare
simple variables.
Results: Between 2003 and 2012, 138 Helical-IBD
devices were placed into 130 patients, beginning in 2008
with a novel device intended for short CIA aneurysms.
Median follow up was 16.2 months (range, 1-72 months)
with 30 day, 1 and 5 year survival rates of 99%, 90%, and
62% respectively. Overall technical success, endoleak and
branch patency, and outcomes between anatomically select
groups are summarised in the Table. No stent fractures or
component separations were noted in the IBDs or mating
devices. Based upon instructions for use for other devices,
only 20% of the patients in this study were candidates for
treatment with an IBD.
Conclusions: The H-IBD has high technical success,
which is detrimentally affected by tight IIA stenosis.
Patency was unaffected by challenging anatomy. The
minority of patients in this trial had anatomy amenable
for treatment with other devices.
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Long-Term Durability of Endovascular Treatment
With Iliac Branch Endograft for Aorto-Iliac Aneurysms
Giovanni Pratesi1, Aaron Fargion2, Raffaele Pulli2, Walter
Dorigo2, Azzurra Guidotti2, Matteo Barbante1, Eleonora
Centonza1, Diego Patacconi1, Martina Battistini1,
Arnaldo Ippoliti1, Carlo Pratesi2. 1Unit of Vascular
Surgery, University of Roma Tor Vergata, Rome, Italy;
2Unit of Vascular Surgery, University of Florence,
Florence, Italy
Objectives: To analyze long-term durability of endo-
vascular treatment (EVAR) for aorto-iliac aneurysm with
the use of iliac branch device (IBD).Methods: A prospective analysis of all patients under-
went EVAR with IBD between September 2007 and
December 2012 was carried out. Main clinical, anatomical
and technical data concerning pre, intra and postoperative
period were prospectively collected into a dedicated data-
base. Follow-up consisted of clinical examination, duplex
scan and computed tomography at 1, 6, 12 months and
yearly thereafter. Data were reported according to the
Kaplan-Meier method.
Results: Ninety-ﬁve EVAR procedures with IBD were
electively carried out in 91 patients. Among the 35 (36.8%)
bilateral iliac aneurysms, four patients (4.2%) received bilat-
eral IBD. Technical success was obtained in 98.9% of cases.
Median follow-up duration was 23.4 months (range 1-63
months). There was one IBD occlusion (1%). Estimated
60 months survival, freedom from reintervention and
branch occlusion was 79.7%, 88.3% and 98.1%, respec-
tively. Seven patients (7.3%), six of them treated for bilat-
eral iliac aneurysms, developed persistent buttock
claudication on the side of hypogastric exclusion whereas
no pelvic ischemic symptoms were observed on the side
of patent IBD.
Conclusions: EVAR for aortoiliac aneurysm using
IBD is durable procedure with low complications and rein-
terventions rates at ﬁve years follow-up. Since no buttock
claudication was observed in patients with patent IBD, it
could be proposed as ﬁrst line treatment whenever anatom-
ically feasible.
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Surveillance Computed Tomographic Arteriogram
(CTA) Is Unnecessary Before Three Years in Patients
Who Have a Normal Post-EVAR Study
Vincent Kirkpatrick, Samuel E. Wilson. Surgery, University
of California Irvine, Orange, Calif
Objectives: Standard surveillance after endovascular
aneurysm repair (EVAR) consists of contrast-enhanced
CT scans, usually at 1 month, 6 months and annually for
5 years. These are expensive and expose patients to neph-
rotoxic contrast and ionizing radiation. We hypothesized
that a normal CTA with no endoleak within 1 month after
EVAR predicts a low rate of future complications, which
would justify a reduction in subsequent CT scans.
Methods: We examined the medical records of 104
patients who underwent EVAR at a single hospital, review-
ing all postoperative CTA’s and noting any complications
